Target Name: CDC42EP1
NCBI ID: G11135
Review Report on CDC42EP1 Target / Biomarker Content of Review Report on CDC42EP1 Target / Biomarker
CDC42EP1
Other Name(s): Cdc42 effector protein 1 | serum protein MSE55 | CDC42 effector protein 1 | serum constituent protein | CDC42 effector protein (Rho GTPase binding) 1 | Binder of Rho GTPases 5 | binder of Rho GTPases 5 | BORG5 | BORG5_HUMAN | Serum constituent protein | Serum protein MSE55 | 55 kDa bone marrow stromal/endothelial cell protein | CEP1 | MSE55

CD42EP1: A Potential Drug Target and Biomarker for Neurodegenerative Disorders

Neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's diseases, are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and neuroglial cells. These conditions are often treated with drugs that aim to slow down or halt the progression of the disease. However, the underlying mechanisms of these diseases remain largely unexplored, and there is a need for new treatments that can specifically target the molecular pathways responsible for these conditions.

CD42EP1: A Potential Drug Target

The protein CD42EP1 has been identified as a potential drug target and biomarker for neurodegenerative diseases. It is a 21-kDa protein that is expressed in various tissues, including brain, heart, and liver. CD42EP1 is involved in the regulation of cell adhesion, migration, and invasion, and has been implicated in the development and progression of several neurodegenerative diseases.

CD42EP1 is a scaffold protein that is involved in the formation of tight junctions, which are specialized junctions that help to maintain the integrity of the blood-brain barrier. It has been shown to be involved in the regulation of neurotransmitter release from axons, and to play a role in the development of neurofibrillary tangles.

CD42EP1 has also been shown to be involved in the regulation of angiogenesis, the formation of new blood vessels in the brain. This is important for the development of neurodegenerative diseases, as the buildup of neurofibrillary tangles and other hallmark pathological changes in the brain is often associated with the formation of new blood vessels.

CD42EP1 as a Biomarker

One of the challenges in the development of new treatments for neurodegenerative diseases is the lack of diagnostic biomarkers that can reliably predict the progression of the disease and the response to new treatments. CD42EP1 may provide a new hope in this regard, as it has been shown to be involved in the regulation of several key processes that are involved in the development and progression of neurodegenerative diseases.

CD42EP1 has been shown to be involved in the regulation of axon growth and differentiation, which are critical processes that are involved in the development of neurotransmitters and the formation of new axons. It has also been shown to be involved in the regulation of microRNA (miRNA) levels, which are small non-coding RNAs that play a critical role in the regulation of gene expression.

CD42EP1 has also been shown to be involved in the regulation of blood-brain barrier (BBB) function, which is the barrier that separates the brain from the blood. The BBB is designed to prevent the entry of foreign substances into the brain, but it can also allow certain molecules to come in and out of the brain. CD42EP1 has been shown to be involved in the regulation of BBB function, which may be important for the development of neurodegenerative diseases.

CD42EP1 as a Potential Drug Target

The identification of CD42EP1 as a potential drug target is based on several studies that have shown its involvement in the regulation of several key processes that are involved in the development and progression of neurodegenerative diseases.

One of the key findings of these studies is that CD42EP1 has been shown to be involved in the regulation of microRNA (miRNA) levels. miRNA are small non-coding RNAs that play a critical role in the regulation of gene expression, and have been shown to play a key role in the development and progression of neurodegenerative diseases.

Another key finding of these studies is that CD42EP1 has been shown to be involved in the regulation of axon growth and differentiation.

Protein Name: CDC42 Effector Protein 1

Functions: Probably involved in the organization of the actin cytoskeleton. Induced membrane extensions in fibroblasts

The "CDC42EP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CDC42EP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CDC42EP2 | CDC42EP3 | CDC42EP4 | CDC42EP5 | CDC42SE1 | CDC42SE2 | CDC45 | CDC5L | CDC5L complex | CDC6 | CDC7 | CDC73 | CDCA2 | CDCA3 | CDCA4 | CDCA4P3 | CDCA5 | CDCA7 | CDCA7L | CDCA8 | CDCP1 | CDCP2 | CDH1 | CDH10 | CDH11 | CDH12 | CDH13 | CDH13-AS2 | CDH15 | CDH16 | CDH17 | CDH18 | CDH19 | CDH2 | CDH20 | CDH22 | CDH23 | CDH24 | CDH26 | CDH3 | CDH4 | CDH5 | CDH6 | CDH7 | CDH8 | CDH9 | CDHR1 | CDHR18P | CDHR2 | CDHR3 | CDHR4 | CDHR5 | CDIN1 | CDIP1 | CDIPT | CDIPTOSP | CDK1 | CDK10 | CDK11A | CDK11B | CDK12 | CDK13 | CDK14 | CDK15 | CDK16 | CDK17 | CDK18 | CDK19 | CDK2 | CDK20 | CDK2AP1 | CDK2AP2 | CDK2AP2P2 | CDK2AP2P3 | CDK3 | CDK4 | CDK5 | CDK5R1 | CDK5R2 | CDK5RAP1 | CDK5RAP2 | CDK5RAP3 | CDK6 | CDK6-AS1 | CDK7 | CDK8 | CDK9 | CDKAL1 | CDKL1 | CDKL2 | CDKL3 | CDKL4 | CDKL5 | CDKN1A | CDKN1B | CDKN1C | CDKN2A | CDKN2A-DT | CDKN2AIP | CDKN2AIPNL